Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$79.72 – $119.00
99% from low
Exchange
ARCX
ETF
Borrow rate
0.92%
Easy to borrow
No company description on file.
No one on the platform currently holds PJP.
No tracked institution reports a position in PJP as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-22 | $0.2733 | 2026-06-26 |
| 2026-03-23 | $0.3090 | 2026-03-27 |
| 2025-12-22 | $0.2463 | 2025-12-26 |
| 2025-09-22 | $0.2363 | 2025-09-26 |
| 2025-06-23 | $0.2668 | 2025-06-27 |
| 2025-03-24 | $0.2729 | 2025-03-28 |
| 2024-12-23 | $0.2232 | 2024-12-27 |
| 2024-09-23 | $0.2004 | 2024-09-27 |
| 2024-06-24 | $0.2105 | 2024-06-28 |
| 2024-03-18 | $0.1695 | 2024-03-22 |
No one on the platform has traded PJP yet.
| 2023-12-18 | $0.1913 | 2023-12-22 |
| 2023-09-18 | $0.2013 | 2023-09-22 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
3/4: CVS Caremark to re-add Lilly’s Zepbound coverage Oct. 1 and cover new obesity pill Foundayo June 1; GLP-1s from Lilly and Novo become co-preferred on standard commercial formulary covering 25M-30M lives. $LLY $NVO $CVS $XLV $PJP
View on StockTwits ↗What was in the news or going on last time $REGN hit a 52 week low? How much (if any) of a dip do you predict if a potential blockbuster competitor receives potential FDA approval in May 2026 or potentially within 1.5 years? Do you think $REGN may dip below 500 within the next 5 years? Do you think opthalmic bevacizumab might receive FDA approval before or after the next presidential election? Do you think OTLK might take a slice of the wet AMD market and more one day? $PFE $LLY $PJP $MRK
View on StockTwits ↗5 Best Health Sector ETFs to Invest in Long Term. Plus 2 honorable mentions. $BBP - Virtus Biotech ETF $FBT - First Trust NYSE® Arca® Biotechnology Index Fund $XBI - State Street® SPDR® S&P® Biotech ETF $PJP - Invesco Pharmaceuticals ETF $IHE - iShares U.S. Pharmaceuticals ETF Honorable mentions: 6. VHT - Vanguard Health Care ETF 7. IHI - iShares U.S. Medical Devices ETF https://x.com/MicahMcDonald8/status/2043521558837354530?s=20
View on StockTwits ↗Why Did CANF Stock Soar 40% In Pre-Market Today? $CANF $CNCR $PJP $XPH https://stocktwits.com/news/equity/markets/why-did-canf-stock-soar-in-pre-market-today/cZd9miARI5F
View on StockTwits ↗Merck Is Reportedly Splitting Its Pharma Division As Keytruda Patent Nears 2028 Expiry $MRK $PPH $PJP $IYH https://stocktwits.com/news/equity/markets/merck-splitting-pharma-division-keytruda-patent-nears-2028-expiry/cZRt85ZR4yE
View on StockTwits ↗FDA Commissioner Raises Concerns About US Pharma Lagging Behind China In Drug Development $IHE $PJP $XPH https://stocktwits.com/news/equity/markets/fda-commissioner-raises-concerns-about-us-pharma-lagging-behind-china-in-drug-development/cZRKIGlR4wT
View on StockTwits ↗$PJP Current Stock Price: $105.14 Contracts to trade: $100 PJP Feb 20 2026 Call Entry: $5.00 Exit: $8.37 ROI: 67% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗Why Did OCUL Stock Jump 13% In Pre-Market Today? $OCUL $VTI $PJP $URTY $SNY https://stocktwits.com/news/equity/markets/why-did-ocul-stock-jump-13-in-pre-market-today/cmU1KclR47Y
View on StockTwits ↗$CORT 6 analysts gave average target of $127 for 250% upside from current $35 level. That said, after today's news, I'm sure analysts will update their targets in coming days and this will come down, but I'm still thinking it'll be over 100% upside potential. $IHE $XPH $PJP $PPH
View on StockTwits ↗$CORT Hitting 52 week low in pre-market. Like to start accumulating near $40 if it can get there. $IHE $XPH $PJP $PPH
View on StockTwits ↗$CORT Tanking -35% in premarket on FDA CRL. Price looks attractive but let me first do some more detail study before entering. $IHE $XPH $PJP $PPH
View on StockTwits ↗#Pharma's $370 Billion #Bet On #America: The #ETF Plays For 2026 $IHE $PJP $PPH Also $ABT $GSK https://talkmarkets.com/content/us-markets/pharmas-370-billion-bet-on-america-the-etf-plays-for-2026?post=546051&userid=123969
View on StockTwits ↗US-UK Near Landmark Zero-Tariffs Pharma Deal, Announcement Expected Soon: Report $AZN $PPH $IHE $PJP https://stocktwits.com/news/equity/markets/us-uk-agree-zero-tariffs-deal-pharmaceuticals/cLI7O6VREiQ
View on StockTwits ↗Pharma ETFs are heating up 💊🔥 A Trump-Pfizer boost is driving fresh momentum, and ETFs like $PPH, $IHE, $PJP & $XPH are looking strong as defensive, undervalued growth plays. See the full 4-reason bull case here 👉 https://www.zacks.com/stock/news/2762423/4-reasons-to-buy-pharma-etfs-now-for-a-healthy-portfolio?cid=sm-stocktwits-2-2762423-teaser-14771&ADID=SYND_STOCKTWITS_TWEET_2_2762423_TEASER_14771
View on StockTwits ↗$BMRN $PPH $PJP $IHE Biomarin Max-Pain inching closer to $60 as more calls get bought... 15% upside?
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.